Amedisys Balance Sheet Health
Financial Health criteria checks 5/6
Amedisys has a total shareholder equity of $1.1B and total debt of $369.3M, which brings its debt-to-equity ratio to 33%. Its total assets and total liabilities are $2.1B and $940.4M respectively. Amedisys's EBIT is $193.1M making its interest coverage ratio 6.9. It has cash and short-term investments of $126.5M.
Key information
33.0%
Debt to equity ratio
US$369.28m
Debt
| Interest coverage ratio | 6.9x |
| Cash | US$126.45m |
| Equity | US$1.12b |
| Total liabilities | US$940.39m |
| Total assets | US$2.06b |
Recent financial health updates
Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?
Feb 25
We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt
Jul 20Is Amedisys (NASDAQ:AMED) A Risky Investment?
Feb 20These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely
Nov 18Amedisys (NASDAQ:AMED) Could Easily Take On More Debt
Aug 18Recent updates
Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 41% Discount?
Apr 10Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?
Feb 25Amedisys (NASDAQ:AMED) Will Be Hoping To Turn Its Returns On Capital Around
Feb 10At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?
Jan 03A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Dec 16Capital Allocation Trends At Amedisys (NASDAQ:AMED) Aren't Ideal
Nov 12Is Now The Time To Look At Buying Amedisys, Inc. (NASDAQ:AMED)?
Sep 19An Intrinsic Calculation For Amedisys, Inc. (NASDAQ:AMED) Suggests It's 38% Undervalued
Sep 04Amedisys: ROIC, Tangible Book Value Each Softening
Aug 24Slowing Rates Of Return At Amedisys (NASDAQ:AMED) Leave Little Room For Excitement
Aug 04Amedisys profit beats by $0.24, revenue misses by $25.23M, 2022 guidance below estimates
Jul 27We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt
Jul 20At US$115, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?
Jun 04Returns On Capital At Amedisys (NASDAQ:AMED) Have Stalled
May 05Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 40% Discount?
Apr 20Does Amedisys (NASDAQ:AMED) Deserve A Spot On Your Watchlist?
Apr 06Is Amedisys (NASDAQ:AMED) A Risky Investment?
Feb 20Amedisys (NASDAQ:AMED) Shareholders Will Want The ROCE Trajectory To Continue
Jan 19Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?
Dec 03These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely
Nov 18Amedisys (NASDAQ:AMED) Could Easily Take On More Debt
Aug 18Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Jul 23Amedisys: Strategic Contessa Acquisition Underpins The Home Healthcare Growth Opportunity
Jul 18Under The Bonnet, Amedisys' (NASDAQ:AMED) Returns Look Impressive
Jun 28It Looks Like Shareholders Would Probably Approve Amedisys, Inc.'s (NASDAQ:AMED) CEO Compensation Package
Jun 02Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?
May 24Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Apr 14Financial Position Analysis
Short Term Liabilities: AMED's short term assets ($496.9M) exceed its short term liabilities ($473.7M).
Long Term Liabilities: AMED's short term assets ($496.9M) exceed its long term liabilities ($466.7M).
Debt to Equity History and Analysis
Debt Level: AMED's net debt to equity ratio (21.7%) is considered satisfactory.
Reducing Debt: AMED's debt to equity ratio has increased from 1.5% to 33% over the past 5 years.
Debt Coverage: AMED's debt is well covered by operating cash flow (37.2%).
Interest Coverage: AMED's interest payments on its debt are well covered by EBIT (6.9x coverage).